Relation between smoking and biomarkers of bone resorption associated with dental endosseous implants

Implant Dentistry

Volumn 13, Issue 4, 2004, Pages 352-357

  Oates, Thomas W ^a   Caraway, Damen ^b   Jones, John ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Biomarkers; Dental implant; Pyridinoline; Smoking

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; METHYLCELLULOSE; PYRIDINOLINE;

ADULT; AGED; ARTICLE; CENTRIFUGATION; ELUTION; ENZYME IMMUNOASSAY; GINGIVITIS; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; SMOKING; STATISTICAL SIGNIFICANCE; TOOTH IMPLANTATION;

ALVEOLAR BONE LOSS; AMINO ACIDS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; GINGIVAL CREVICULAR FLUID; HUMANS; IMMUNOASSAY; SMOKING;

EID: 11444264091     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000148563.11256.of     Document Type: Article

References (21)

1. Lindquist LW, Carlsson GE, Jemt T. Association between marginal bone loss around osseointegrated mandibular implants and smoking habits: a 10-year follow-up study. J Dent Res Assoc. 1997;76:1667-1674.
2. Karoussis IK, Muller S, Salvi GE, et al. Association between periodontal and peri-implant conditions: a 10-year prospective study. Clin Oral Implants Res. 2004:15:1-7.
3. van Steenberghe D, Jacobs R, Desnyder M, et al. The relative impact of local and endogenous patient-related factors on implant failure up to the abutment stage. Clin Oral Implants Res. 2002;13:617-622.
4. Mombelli A. Etiology, diagnosis, and treatment considerations in periimplantitis. Curr Opin Periodontol. 1997;4: 127-136.
5. Koutsonikos A. Implants: success and failure - a literature review. Ann Royal Australasian Coll Dental Surgeons. 1998;14:75-80.
6. Haffajee AD, Socransky SS, Lindhe J, et al. Clinical risk indicators for periodontal attachment loss. J Clin Periodontol. 1991;18:117-125.
7. Giannobile WV, Lynch SE, Denmark RG, et al. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis: a pilot study in beagle dogs. J Clin Periodontol. 1995;22:903-910.
8. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol. 1997;2:123-137.
9. Risteli J, Elomaa I, Niemi S, et al. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 1993;39:635-640.
10. Seibel MJ, Woitge HW. Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. J Clin Densitom. 1999;2:299-321.
11. Talonpoika JT, Hamalainen MM. Type I carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol. 1994;21:21-34.
12. Oates TW, Graves DT, Cochran DL. Clinical, radiographic and biochemical assessment of IL-1/TNF-α antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol. 2002;29:137-143.
13. Assuma R, Oates TW, Cochran DL, et al. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol. 1998;160:403-409.
14. Jones JD, Saigusa M, Van Sickels JE, et al. Clinical evaluation of hydroxyapatite-coated titanium plasma-sprayed and titanium plasma-sprayed cylinder dental implants: a preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:137-141.
15. Jones JD, Lupori J, Van Sickels JE, et al. A 5-year comparison of hydroxyapatite-coated titanium plasmasprayed and titanium plasma-sprayed cylinder dental implants. Oral Surg Oral Med Oral Pathol. 1999;87:649-652.
16. Armitage GC. Periodontal disease: diagnosis. Ann Periodontol. 1996;1:37-215.
17. Cochran DL. Implant therapy I. Ann Periodontol. 1996;1:707-790.
18. Palys MD, Haffajee AD, Socransky SS, et al. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J Clin Periodontol. 1998;25:865-871.
19. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997;46:310-319.
20. Giannobile WV. Crevicular fluid biomarkers of oral bone loss. Curr Opin Periodontol. 1997;4:11-20.
21. Oringer RJ, Palys MD, Iranmanesh A, et al. C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Impl Res. 1998;9:365-373.